Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a $20 million commitment to CNote, a technology-based investment platform. The investment will support economic growth and opportunity in communities across the U.S. by providing capital to support BIPOC-owned (Black, Indigenous, and people of color) and women-led small businesses.

“Our partnership with CNote is an extension of our ongoing commitment to strengthen the communities where we live and work,” said Belén Garijo, Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. “We see this partnership as a tangible way to support entrepreneurs and small businesses—in particular, historically underfunded BIPOC-led businesses—and have a significant and measurable impact on expanding economic opportunities throughout these communities.”

CNote is a women-led, certified B-Corporation that creates real change by building more economically inclusive communities. CNote deploys investor funds into deposit and loan products at community financial institutions that have a long track record of financial stability and serve low-income women and people of color entrepreneurs, fund affordable housing, and support other forms of economic inclusion. By using technology to foster greater economic and social justice through investments, CNote funds vital community development projects that create jobs and affordable housing, and help small businesses grow.

“Equity is a cornerstone of our DE&I strategy. We believe that diversity, equity and inclusion are not only about numbers but also about actions,” said Renee Connolly, Chief Diversity, Equity & Inclusion Officer and Head of Innovation HR Engagement & Inclusion at Merck KGaA, Darmstadt, Germany. “This partnership enables us to expand the way we can drive equitable financial access in communities where we operate — which is critical to the long-term economic vitality of those communities — and thus further our DE&I strategy.”

The investment will be directed to communities where Merck KGaA, Darmstadt, Germany has substantial operations, including Arizona, California, Maryland, Massachusetts, Missouri, New Hampshire, Ohio, Pennsylvania, Texas, Washington and Wisconsin.

Find out more about the company’s diversity and inclusion program on its website.

MilliporeSigma

MilliporeSigma

We holistically integrate sustainability throughout our own operations and across suppliers, reducing the impact of scientific research globally and exceeding customer expectations.

The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 26,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.  

Around 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2024, Merck KGaA, Darmstadt, Germany, generated sales of € 21.2 billion in 65 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.

More from MilliporeSigma